Pridopidine in Amyotrophic Lateral Sclerosis

Overview of attention for article published in JAMA: Journal of the American Medical Association, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 32 news outlets
blogs: 3 blogs
twitter: 10 X users
facebook: 3 Facebook pages

reddit: 1 Redditor
video: 1 YouTube creator
bluesky: 4 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 3 posts from 3 blogs.

KMN 2025: How Accelerated drug-testing platform for ALS paves manner for therapeutic innovation

Health Medicine Network, 18 Feb 2025

An MRI with elevated sign within the posterior a part of the inner capsule which could be tracked to the motor cortex in…

Groundbreaking ALS platform trial accelerates research and drug testing

news-medical.net, 17 Feb 2025

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M.

Evaluating Treatments for Amyotrophic Lateral Sclerosis

JAMA Author Interviews, 17 Feb 2025

The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression.

This page shows the most recent blog posts that mention this research output. Click here to find out how to access more activity.